Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003.
Coste
J
J
EFS Pyrénées-Méditerranée Laboratoire de R&D, F-34000 Montpellier, France. joliette.coste@efs.sante.fr
Reesink
H W
HW
Engelfriet
C P
CP
Laperche
S
S
Brown
S
S
Busch
M P
MP
Cuijpers
H T
HT
Elgin
R
R
Ekermo
B
B
Epstein
J S
JS
Flesland
O
O
Heier
H E
HE
Henn
G
G
Hernandez
J M
JM
Hewlett
I K
IK
Hyland
C
C
Keller
A J
AJ
Krusius
T
T
Levicnik-Stezina
S
S
Levy
G
G
Lin
C K
CK
Margaritis
A R
AR
Muylle
L
L
Niederhauser
C
C
Neiderhauser
C
C
Pastila
S
S
Pillonel
J
J
Pineau
J
J
van der Poel
C L
CL
Politis
C
C
Roth
W K
WK
Sauleda
S
S
Seed
C R
CR
Sondag-Thull
D
D
Stramer
S L
SL
Strong
M
M
Vamvakas
E C
EC
Velati
C
C
Vesga
M A
MA
Zanetti
A
A
D001782:Blood Donors; D015497:HIV-1 / Q000235:genetics; D016174:Hepacivirus / Q000235:genetics; D006801:Humans; D007391:International Cooperation; D008403:Mass Screening / Q000379:methods* / Q000592:standards / Q000639:trends; D021141:Nucleic Acid Amplification Techniques / Q000379:methods* / Q000706:statistics & numerical data; D012367:RNA, Viral / Q000097:blood; D012680:Sensitivity and Specificity; D065227:Transfusion Reaction; D014777:Virus Diseases / Q000175:diagnosis* / Q000635:transmission
D012367:RNA, Viral